Antidiarrheal drug products for over-the-counter human use; final monograph. Final rule.
The Food and Drug Administration (FDA) is issuing a final rule in the form of a final monograph establishing conditions under which over-the-counter (OTC) antidiarrheal drug products (to control the symptoms of diarrhea) are generally recognized as safe and effective and not misbranded. This final rule is part of FDA's ongoing review of OTC drug products. FDA is issuing this final rule after considering public comments on the agency's proposed regulation, which was issued in the form of a tentative final monograph (TFM), and all new data and information on OTC antidiarrheal drug products that have come to the agency's attention. Also, this final rule amends the regulation that lists nonmonograph active ingredients by adding those OTC antidiarrheal active ingredients that have been found to be not generally recognized as safe and effective.
D000930:Antidiarrheals / Q000145:classification*; D006801:Humans; D007880:Legislation, Drug; D004366:Nonprescription Drugs / Q000145:classification*; D011356:Product Labeling / Q000331:legislation & jurisprudence*; D012202:Reye Syndrome / Q000139:chemically induced; D014481:United States; D014486:United States Food and Drug Administration
D000930:Antidiarrheals; D004366:Nonprescription Drugs